Collectively, these results demonstrate that, similar to the genetic inhibition of EHMT2, pharmacological inhibition of EHMT2 and TGF-β1 results in tumor suppression and increased NK cell infiltration. The gene discussed is TGFB1; the disease is neoplasm.